Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02484430
Title TORC1/2 Inhibitor INK128 in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute lymphoblastic leukemia

Therapies

Sapanisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Los Angeles County-USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Kansas Clinical Research Center Fairway Kansas 66205 United States Details
University of Kansas Cancer Center Kansas City Kansas 66160 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field